未登录

O

Oliver G. Bosch

University of Zurich

H指数:23

被引数:1,748

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gamma-hydroxybutyrate to promote slow-wave sleep in major depressive disorder: a randomized crossover trial

NEUROPSYCHOPHARMACOLOGY

IF7.1

2025-04-010

OAAI

REPURPOSING OF GAMMA-HYDROXYBUTYRATE IN DEPRESSION: A RANDOMIZED PLACEBO-CONTROLLED PROOF-OF-CONCEPT CLINICAL TRIAL

γ-羟基丁酸在抑郁症中的新用途：一项随机、安慰剂对照的概念验证临床试验

INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

IF3.7

2025-02-120

OA

Urinary concentrations of GHB and its novel amino acid and carnitine conjugates following controlled GHB administration to humans

SCIENTIFIC REPORTS

IF3.9

2023-06-021

OAAI

Nocturnal sodium oxybate increases the anterior cingulate cortex magnetic resonance glutamate signal upon awakening

JOURNAL OF SLEEP RESEARCH

IF3.9

2023-03-034

OAAI

Dexmedetomidine in Psychiatry: Repurposing of its Fast-Acting Anxiolytic, Analgesic and Sleep Modulating Properties

PHARMACOPSYCHIATRY

IF2.2

2022-11-168

OA

Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophrenia

JOURNAL OF PSYCHIATRIC RESEARCH

IF3.2

2022-01-0117

OAAI

Towards Extending the Detection Window of Gamma-Hydroxybutyric Acid-An Untargeted Metabolomics Study in Serum and Urine Following Controlled Administration in Healthy Men

IF3.7

2021-03-1215

OAAI

Neurophysiological signature of gamma-hydroxybutyrate augmented sleep in male healthy volunteers may reflect biomimetic sleep enhancement: a randomized controlled trial

NEUROPSYCHOPHARMACOLOGY

IF7.1

2019-04-0816

OAAI

Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use Severity

FRONTIERS IN PSYCHIATRY

IF3.2

2019-04-0521

OAAI

Effects of gamma-hydroxybutyrate on neurophysiological correlates of performance and conflict monitoring

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2019-04-015

OAAI

Socio-cognitive functioning in stimulant polysubstance users

DRUG AND ALCOHOL DEPENDENCE

IF3.6

2018-09-0122

OAAI

Neural Underpinnings of the Hedonic Effects of Gamma-Hydroxybutyrate in Humans

BIOLOGICAL PSYCHIATRY

IF9

2018-05-010

PREAI

The potential impact of biochemical mediators on telomere attrition in major depressive disorder and implications for future study designs: A narrative review

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2018-01-0123

PREAI

Resting state brain network function in major depression - Depression symptomatology, antidepressant treatment effects, future research

抑郁症的静息态脑网络功能-抑郁症症状学，抗抑郁药治疗效果，未来研究

JOURNAL OF PSYCHIATRIC RESEARCH

IF3.2

2017-09-01255

PREAI

Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs

FRONTIERS IN PSYCHIATRY

IF3.2

2017-08-1835

OAAI

Gamma-Hydroxybutyrate Increases Resting-State Limbic Perfusion and Body and Emotion Awareness in Humans

NEUROPSYCHOPHARMACOLOGY

IF7.1

2017-05-3118

OAAI

Neuronal oscillations and synchronicity associated with gamma-hydroxybutyrate during resting-state in healthy male volunteers

PSYCHOPHARMACOLOGY

IF3.3

2017-04-2013

PREAI

Neural underpinnings of prosexual effects induced by gamma-hydroxybutyrate in healthy male humans

EUROPEAN NEUROPSYCHOPHARMACOLOGY

IF6.7

2017-04-0119

PREAI

The behavioural profile of gamma-hydroxybutyrate, gamma-butyrolactone and 1,4-butanediol in humans

BRAIN RESEARCH BULLETIN

IF3.7

2016-09-0118

PREAI

Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

IF3

2016-02-2555

OAAI